Clinical Trial Update: RElugolix VErsus LeUprolide Cardiac Trial [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Relugolix to Leuprolide in biochemically recurrent and localized prostate cancer; results have been posted as of 2025-09-22 and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide (Leuprolide acetate)
• Relugolix (Relugolix)

Snippet

Sponsor: Emory University | Conditions: Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-22